Immerse yourself in CGT policy discussions at the Policy Summit, Sept. 18-19!
Learn more about sessions and presentations at the 26th Annual Meeting
Saturday, May 20 2023 10:15 AM – 12:00 PM PT
Delivery of genetic therapies to the airway epithelium presents unique challenges for a long-lasting therapeutic for people with cystic fibrosis (CF). The CF lung is characterized by thick, sticky mucus that dehydrates due to the loss of functional cystic fibrosis transmembrane conductance regulator (CFTR) channels. Dehydration of the mucus and plugging of the airway lead to reduced lung function and restricted distribution of inhaled aerosolized vector. Systemic delivery likely requires engineered vector tropism and the capacity to navigate from the vasculature to the epithelium. This symposium will bring together leaders in the nanotechnology field to present and discuss novel technologies and strategies to deliver genetic therapies to the lung.
10:15 AM – 12:00 PM - Room 502 AB
John D. Lueck, PhD. University of Rochester, School of Medicine and Dentistry, Rochester, NY
Brigitte Gomperts, MD. UCLA, CA
10:16 AM – 10:35 AM - Room 502 AB
John F. Engelhardt, Ph.D.. University of Iowa, Iowa City, IA
10:35 AM – 10:55 AM - Room 502 AB
10:55 AM – 11:15 AM - Room 502 AB
Gaurav Sahay, PhD. Oregon State University, OR
11:15 AM – 11:35 AM - Room 502 AB
Alexandra S.. Piotrowski-Daspit, Ph.D.. University of Michigan, Ann Arbor, MI
11:35 AM – 11:55 AM - Room 502 AB
Sriram Vaidyanathan, PhD. Nationwide Children's Hospital, Columbus, OH
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico